跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Atrimustine
首页
药物
Atrimustine
Atrimustine
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
An anticancer sustained release injection carrying tumor drug resistance reversal agent and cytotoxic drug simultaneously
CN 1875930 A
申请人: JINAN KANGQUAN PHARMACEUTICAL
优先权: 2006
CN
Sustained release anticancer agent carrying angiogenesis inhibitor and cytotoxic drug
CN 1875933 A
申请人: JINAN KANGQUAN PHARMACEUTICAL
优先权: 2006
CN
A sustained release injection carrying clorfarabine and cytotoxic drug
CN 1875937 A
申请人: JINAN KANGQUAN PHARMACEUTICAL
优先权: 2006
CN
Slow release injection loading both tetrazole violet and cytotoxic drug
CN 1927178 A
申请人: JINAN SHUAIHUA PHARMACEUTICAL
优先权: 2006
CN
Anticancer sustained-released gel injection and preparation method thereof
CN 101336891 A
申请人: JINAN JIFU MEDICINE SCIENCE AN
优先权: 2008
CN
药物
反馈